Bioshares Biotechnology Products Fund ETF Forecast

Sell candidate since Jun 01, 2026 Gain 0.02%

The BioShares Biotechnology Products Fund ETF price gained 1.10% on the last trading day (Wednesday, 3rd Jun 2026), rising from $83.56 to $84.48. During the last trading day the ETF fluctuated 0.428% from a day low at $84.18 to a day high of $84.54. The price has been going up and down for this period, and there has been a 0.38% gain for the last 2 weeks. Volume fell on the last day by -11 thousand shares and in total, 4 thousand shares were bought and sold for approximately $365.71 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The ETF lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the ETF is expected to rise 6.37% during the next 3 months and, with a 90% probability hold a price between $87.60 and $97.92 at the end of this 3-month period.

BBP Signals & Forecast

There are few to no technical positive signals at the moment. The BioShares Biotechnology Products Fund ETF holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the ETF. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $85.82 and $86.27. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 06, 2026, and so far it has fallen -6.54%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for BioShares Biotechnology Products Fund ETF

BioShares Biotechnology Products Fund finds support from accumulated volume at $83.67 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the ETF tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the ETF. During the last day, the ETF moved $0.360 between high and low, or 0.428%. For the last week the ETF has had daily average volatility of 1.76%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BBP) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect BioShares Biotechnology Products Fund to open at $84.40, and during the day (based on 14 day Average True Range), to move between $83.73 and $85.23, which gives a possible trading interval of +/-$1.51 (+/-1.80%) up or down from last closing price. If BioShares Biotechnology Products Fund takes out the full calculated possible swing range there will be an estimated 1.80% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $85.11 (0.75%) than the support at $83.67 (0.96%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is BioShares Biotechnology Products Fund ETF A Buy?

The BioShares Biotechnology Products Fund ETF holds several negative signals and despite the positive trend, we believe BioShares Biotechnology Products Fund will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this ETF.

Current score: -2.112 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $84.40 ( 0.0947%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk